In Brief: Adeza female infertility test
This article was originally published in The Gray Sheet
Adeza female infertility test: Adeza Biomedical plans worldwide launch of E-tegrity test for female infertility on Jan. 1. The assay detects the B-3 integrin protein in uterine fundus tissue. "It appears that some women with unexplained infertility may have biochemical alterations affecting uterine function that can now be detected using the E-tegrity test," the company says. Adeza performs the test at its clinical laboratory, with results available in "less than 14 days"...
You may also be interested in...
Dr Reddy's is poised to expand its OTC offering in Russia and certain CIS countries by snapping up a basket of allergy brands from fellow Indian firm Glenmark.
Sandoz has launched an awareness campaign under the banner of “Ask For Generics” in the US. The initiative is aiming to educate stakeholders on the benefits of generics and their quality, safety and efficacy.
European Commission proposals for strengthening intellectual property protections in the EU, particularly the supplementary protection certificate (SPC) system, have been broadly welcomed by Europe’s brand industry. But the medical NGO, MSF, says the SPC proposals run counter to the commission’s own efforts to improve access to medicines.